MUZII, LUDOVICO
 Distribuzione geografica
Continente #
NA - Nord America 11.528
EU - Europa 5.531
AS - Asia 2.818
AF - Africa 201
SA - Sud America 129
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.304
Nazione #
US - Stati Uniti d'America 11.336
IT - Italia 2.476
SG - Singapore 1.052
IN - India 642
SE - Svezia 541
DE - Germania 534
CN - Cina 511
FI - Finlandia 352
RU - Federazione Russa 351
UA - Ucraina 226
GB - Regno Unito 219
CA - Canada 139
TR - Turchia 118
AT - Austria 109
IE - Irlanda 108
BG - Bulgaria 90
AU - Australia 80
TG - Togo 79
ID - Indonesia 78
BE - Belgio 66
NL - Olanda 65
FR - Francia 62
AR - Argentina 49
ES - Italia 48
TW - Taiwan 47
GR - Grecia 46
BR - Brasile 45
IR - Iran 45
MX - Messico 45
PH - Filippine 44
RO - Romania 42
CH - Svizzera 39
PK - Pakistan 38
EG - Egitto 34
HK - Hong Kong 32
PL - Polonia 31
IQ - Iraq 29
JP - Giappone 29
IL - Israele 28
LT - Lituania 28
MY - Malesia 26
ZA - Sudafrica 26
KR - Corea 21
PT - Portogallo 19
HU - Ungheria 14
NZ - Nuova Zelanda 14
NG - Nigeria 13
NO - Norvegia 13
CO - Colombia 12
TH - Thailandia 11
CL - Cile 10
LV - Lettonia 10
KE - Kenya 9
KZ - Kazakistan 9
YE - Yemen 9
DK - Danimarca 8
EC - Ecuador 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
VN - Vietnam 8
ET - Etiopia 7
SC - Seychelles 7
HR - Croazia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
GH - Ghana 5
MA - Marocco 5
PE - Perù 5
TZ - Tanzania 5
BD - Bangladesh 4
JO - Giordania 4
LA - Repubblica Popolare Democratica del Laos 4
MK - Macedonia 4
AL - Albania 3
AZ - Azerbaigian 3
BF - Burkina Faso 3
CI - Costa d'Avorio 2
CU - Cuba 2
CZ - Repubblica Ceca 2
EU - Europa 2
GT - Guatemala 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MV - Maldive 2
PA - Panama 2
QA - Qatar 2
TJ - Tagikistan 2
TN - Tunisia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
KW - Kuwait 1
LU - Lussemburgo 1
Totale 20.302
Città #
Fairfield 1.894
Ashburn 933
Woodbridge 881
Rome 877
Singapore 734
Chandler 701
Seattle 700
Wilmington 633
Houston 624
Cambridge 603
Ann Arbor 377
Beijing 333
Princeton 331
Santa Clara 274
San Paolo di Civitate 241
Plano 222
Lawrence 173
Helsinki 163
Boston 162
Dearborn 151
Millbury 151
San Diego 141
Milan 110
Bremen 101
Vienna 92
Andover 89
Sofia 87
Lomé 79
Dublin 75
Jacksonville 73
Moscow 72
Jakarta 66
Toronto 63
Brussels 60
Norwalk 60
New York 52
Stockholm 46
Federal 45
Los Angeles 43
Des Moines 42
Boardman 34
Falkenstein 34
Istanbul 32
Falls Church 29
Yubileyny 27
Redwood City 26
Sydney 26
Florence 25
London 23
Galway 22
Munich 22
Ottawa 22
Fremont 21
Melbourne 21
Naples 21
Phoenix 21
Frankfurt am Main 20
Mannheim 20
Antalya 18
Bologna 18
Bühl 18
Tokyo 18
Hefei 17
San Mateo 17
Mumbai 16
Vilnius 16
Ankara 15
Birmingham 15
Cairo 15
Dallas 15
Hong Kong 15
Hyderabad 15
North York 15
Paris 15
Pune 15
Angeles City 14
Brescia 14
Manchester 14
Nuremberg 14
Quezon City 14
Tehran 14
Tel Aviv 14
Berlin 13
Kunming 13
Mexico City 13
Chicago 12
Karachi 12
Nanjing 12
Parma 12
Verona 12
Amsterdam 11
Hamilton 11
Kaohsiung City 11
Pescara 11
Sulaymaniyah 11
Bengaluru 10
Brisbane 10
Kuala Lumpur 10
Lappeenranta 10
Monterotondo 10
Totale 13.575
Nome #
D-mannose: a promising support for acute urinary tract infections in women. A pilot study 791
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers. State of Art and Future Perspectives 649
L’intervento secondo Lahodny 242
Maternal and perinatal outcomes of pregnant women with SARS-COV-2 infection 233
Colporrafia anteriore più TVT-O per il trattamento dell’incontinenza urinaria da sforzo associata a cistocele: uno studio pilota. 194
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis 151
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 149
The Efficacy of Fractional {CO}2 Laser in the Treatment of Genitourinary Syndrome of Menopause. A Large Prospective Observational Study 141
Efficacy of n-acetylcysteine on endometriosis-related pain, size reduction of ovarian endometriomas, and fertility outcomes 136
Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases 131
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer 126
Fertility preservation in gynaecologic cancers 112
Endometrioma-associated infertility: is surgery still the best way to go? 111
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers 109
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 108
Management of hydrosalpinx before IVF: A literature review. 107
Autologous In Vitro Cultured Vaginal Tissue for Women Subjected to the Abbe-McIndoe Vaginoplasty: A Case Series 105
Dose-dense weekly chemotherapy in advanced ovarian cancer: an updated meta-analysis of randomized controlled trials 105
Bevacizumab in ovarian cancer: state of the art and unanswered questions 102
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis 102
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know 100
3-D ultrasound in the study of placental vascularization. Application of vocal technique. A case-control study and a review of literature 99
Pelvic lymphadenectomy for cervical carcinoma: Laparotomy extraperitoneal, transperitoneal or laparoscopic approach? A randomized study 98
Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome. outcome after 6 months of treatment with ospemifene 97
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 96
Immune check-point in cervical cancer 95
Alpha lipoic acid in obstetrics and gynecology 94
Fertility preservation in ovarian tumours 94
Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386) 92
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 92
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women 92
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis 90
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 90
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis 90
All we know about COVID-19 in pregnancy: from perinatal to ethical and psychological perspective 90
Continuous versus cyclic oral contraceptives for endometriosis: any conclusive evidence? 89
Adenomyosis. what the patient needs 89
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients. A prospective cohort study 89
null 88
Ixabepilone for the treatment of endometrial cancer 88
PARP inhibition: a promising therapeutic target in ovarian cancer 88
Unexpected Metastasis of High Grade Serous Ovarian Cancer to Breast: Case Report and Literature Review 88
Treatment of the Mayer-Rokitansky-Küster-Hauser syndrome with autologous in vitro cultured vaginal tissue. descriptive study of long-term results and patient outcomes 88
GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study 86
Mechanical bowel preparation before gynecologic laparoscopy: a randomized, single-blind, controlled trial 86
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: technique and feasibility. 85
null 85
Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma. Younger and older patients should be equally treated. A prospective study and literature review 85
Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer 85
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 83
Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies 83
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy 83
Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy. improvement of sexuality? 83
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients 82
Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment 82
Cervical cancer: are there potential new targets? An update on preclinical and clinical results 81
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 81
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 80
Immunotherapy in endometrial cancer: new scenarios on the horizon 80
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 80
Sperm DNA Fragmentation and Sperm-Borne miRNAs: Molecular Biomarkers of Embryo Development? 79
Eritropoietina e darbopoietina in corso di chemioterapia neoadiuvante. 79
Characterization of the vaginal microbiota in Italian women with endometriosis. Preliminary study 78
Cediranib in ovarian cancer. state of the art and future perspectives 78
Management of endometriomas 78
Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: a retrospective analysis 78
CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results. 77
Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain 77
The unexpected ovarian malignancy found during operative laparoscopy: Incidence, management, and implications for prognosis 77
A new type of absorbable barbed suture for use in laparoscopic myomectomy 76
Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma 76
Ovarian reserve reduction with surgery is not correlated with the amount of ovarian tissue inadvertently excised at laparoscopic surgery for endometriomas 76
Minilaparotomy hysterectomy: A valid option for the treatment of benign uterine pathologies 75
Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: Is it feasible and safe? 75
Long-Term Bladder Function in Patients with Locally Advanced Cervical Carcinoma Treated with Neoadjuvant Chemotherapy and Type 3-4 Radical Hysterectomy 75
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 75
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy 75
Oral estroprogestins after laparoscopic surgery for endometriomas: continuous or cyclic administration? Results of a multicentric randomized study 75
Long-term experience of vaginal vault prolapse prevention at hysterectomy time by modified McCall culdoplasty or shull suspension. clinical, sexual and quality of life assessment after surgical intervention 74
Autologous in vitro cultured vaginal tissue for vaginoplasty in women with Mayer-Von-Rokitansky-Küster-Hauser syndrome: anatomical and functional results 74
Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks. improvement in overactive bladder symptoms 74
Miomectomia laparoscopica: fattibilità e learning curve. 73
[Prevention of postoperative adhesions]. 73
Pelvic inflammatory disease. possible catches and correct management in young women 73
Continent ileocolonic urinary diversion (Rome pouch) for gynecologic malignancies: Technique and feasibility 72
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 72
Reply: "An expert forum for the histologic of endometriomas" 72
null 72
Guidelines of how to manage vesicovaginal fistula 72
Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials.part II: evaluation of tolerability and safety 72
Detection of twin reversed arterial perfusion sequence at the time of first ultrasound screening and its spontaneous resolution. A case report 72
An update in neoadjuvant chemotherapy in cervical cancer 72
Therapeutic Approaches to Vulvar Cancer. A Review of Literature 71
Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis 71
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer 71
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature 71
Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome 71
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 71
Accuracy of pelvic ultrasound in preoperative evaluation of uterine myomas: a prospective cohort study 70
The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. 70
Totale 10.392
Categoria #
all - tutte 65.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.138 0 0 0 0 0 0 505 447 446 393 237 110
2020/20211.593 159 161 71 167 83 98 71 114 139 155 218 157
2021/20223.075 69 129 257 98 376 180 93 307 298 204 471 593
2022/20233.541 661 655 164 399 326 307 112 215 332 74 172 124
2023/20242.824 209 287 151 301 277 266 145 334 30 333 199 292
2024/20253.264 210 442 368 396 777 589 482 0 0 0 0 0
Totale 21.524